Bioceres Crop Solutions Corp

Bioceres Crop Solutions Corp. engages in the provision of crop productivity solutions. The firm includes seeds, seed traits, seed treatments, biologicals, high-value adjuvants and fertilizers. It operates through the following segments: Seed and Integrated Products, Crop Protection, and Crop Nutrition. The Seed and Integrated Products segment deals with the development and commercialization of integrated products that combine three complementary components biotechnological events, germplasm and seed treatments in order to increase crop productivity and create value for customers. The Crop Protection segment develops and produces adjuvants, insecticides and fungicides. The Crop Nutrition segment focuses on the development, production and commercialization of inoculants that allow the biological fixation of nitrogen in the crops and of fertilizers including bio fertilizers and micro granulated fertilizers that increases the productivity and yield of the crops. The company was founded on November 14, 2017 and is headquartered in Rosario, Argentina.

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Bioceres Crop Solutions Reports Strong Q1 2023 Performance and Promising Growth Opportunities

BIOC's Q1 2023 showcased robust revenue and profit growth, driven by the crop nutrition segment and strategic partnerships. While weather conditions in Argentina posed challenges, the company's financial health improved significantly. The approval of HB4 grain importation in Brazil and progress in the Pro Farm front present promising opportunities for future growth.

Bioceres Crop Solutions Corp reports flat revenue, focuses on HB4 technology for growth

Bioceres Crop Solutions Corp faces challenges from severe drought impacting sales but shows strength in HB4 technology performance and revenue growth. The company aims for sales growth and profitability despite weather-related challenges. Opportunities lie in expanding HB4 technology globally and providing farmers with certainty in harvests.

Bioceres reports robust Q3 earnings, eyes growth through strategic partnerships

Bioceres Crop Solutions Corp delivered strong financial performance in Q3 2023, driven by revenue growth, improved profitability, and strategic partnerships.
While facing challenges from market disruptions and weather impacts, the company maintains a stable financial position and remains optimistic about future prospects.
With a focus on innovation, partnerships, and sustainability, Bioceres is well-positioned to capitalize on growth opportunities and navigate industry challenges effectively.

Bioceres Crop Solutions Corp achieves record revenues in Q4 2023

Bioceres Crop Solutions Corp delivered strong financial performance in Q4 2023, with record revenues, gross profit expansion, and increased adjusted EBITDA. The company faces challenges in flat revenues and inventory drawdown but is focused on higher margin products and strategic partnerships for growth. Opportunities exist in expanding product lines and partnerships for future revenue growth.

Bioceres Crop Solutions Corp reports strong Q1 earnings and global expansion opportunities

Bioceres Crop Solutions Corp's Q1 2024 performance reflects robust financial growth and strategic advancements in technology and market expansion.
While facing challenges in hedging and inventory valuation, the company is well-positioned to capitalize on opportunities in new markets and product offerings.
Overall, the company's optimistic outlook for fiscal '24, supported by strong financials and innovative initiatives, signals a promising path for growth and shareholder value.

Bioceres Crop Solutions Corp reports stellar Q2 results and eyes sustained growth amidst market challenges

Bioceres Crop Solutions Corp delivered robust financial performance in Q2 2024, driven by revenue growth, improved net income, and strong EBITDA. The company's focus on innovation, market execution, and technological advancements positions it well for sustained growth despite challenges in key markets.

Bioceres Crop Solutions reports Q3 revenue decline, eyes U.S. growth

Bioceres Crop Solutions Corp faced revenue declines in Q3 due to the Syngenta distribution agreement impact but saw growth in key segments. Despite challenges, the company remains optimistic about significant profitability improvement in Q4 and continued double-digit growth. Expansion plans in the U.S. market and new product launches in Brazil present growth opportunities.

Bioceres reports record revenue, eyes growth through innovation and profitability

Bioceres Crop Solutions Corp delivered strong financial performance amidst challenges, with a focus on profitability and innovation.
The company faces revenue-related challenges but is strategically positioned to capitalize on market opportunities and drive growth.
Management's emphasis on efficiency, profitability, and leveraging biological products signals a clear strategic direction for future success.

Bioceres reports revenue decline, focuses on innovation and profitability

Bioceres Crop Solutions Corp faced revenue challenges in Q1 2025 but demonstrated strength in key markets and innovation.
The company is strategically navigating challenges in product segments while focusing on profitability and operational efficiency.
Opportunities lie in driving growth through cash generation, market expansion, and maintaining a competitive edge in the industry.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Bioceres Crop Solutions Corp. (NASDAQ:BIOX ) Q4 2022 Earnings Conference Call September 8, 2022 8:30 AM ET Company Participants Paula Savanti - Head of Investor Relations Federico Trucco - Chief Executive Officer Enrique López Lecube - Chief Financial Officer Conference Call Participants Ben Klieve - Lake Street Capital Markets Kemp Dolliver - Brookline Capital Markets Dmitry Silversteyn - Water Tower Research Operator Hello and welcome to the Bioceres Crop Solutions Fiscal Fourth Quarter 2022 Financial Results Conference Call. My name is Alex.

Bioceres Crop Solutions Corp. (BIOX) Q4 2022 - Earnings Call Transcript

ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions Corp. (“Bioceres”) (NASDAQ: BIOX), a fully integrated provider of crop productivity solutions designed to enable the transition of agriculture towards carbon neutrality, announced financial results for the fiscal fourth quarter and fiscal year ended June 30, 2022. Financial results are expressed in US dollars and are presented in accordance with International Financial Reporting Standards. All comparisons in this announcement are year

Bioceres Crop Solutions Reports Fiscal Fourth Quarter and Full-Year 2022 Financial and Operational Results

ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions to Host Fiscal Fourth Quarter and Full Year 2022 Financial Results Conference Call Thursday, September 8, 2022 at 8:30 a.m. ET

Bioceres Crop Solutions to Host Fiscal Fourth Quarter and Full Year 2022 Financial Results Conference Call on Thursday, September 8, 2022 at 8:30 a.m. Eastern Time

ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions Executed Previously Announced Financing Agreements for a Total Amount of $79 Million

Bioceres Crop Solutions Executed Previously Announced Financing Agreements for a Total Amount of $79 Million

ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions to Participate in the Canaccord Genuity 42nd Annual Growth Conference

Bioceres Crop Solutions to Participate in the Canaccord Genuity 42nd Annual Growth Conference

Marrone Bio Innovations

ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions completes merger with Madrone Bio, creating a global leader in sustainable agricultural solutions

Bioceres Crop Solutions Completes Merger With Marrone Bio, Creating a Global Leader in Sustainable Agricultural Solutions

ROSARIO, Argentina--(BUSINESS WIRE)--FDA Favorably Concludes HB4® Wheat Food and Feed Safety Evaluation

FDA Favorably Concludes HB4® Wheat Food and Feed Safety Evaluation

ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions to Participate at ROTH 8th Annual London Conference June 21-23, 2022

Bioceres Crop Solutions to Participate at ROTH 8th Annual London Conference June 21-23, 2022

Arcadia Biosciences

–  Sales increased 48% from Q4 2021 – – First retail orders of GoodWheat™  pasta shipped – – HB4® soybeans approved in China, $2M milestone anticipated – DAVIS, Calif. , May 12, 2022 /PRNewswire/ --  Arcadia Biosciences, Inc.

Arcadia Biosciences (RKDA) Announces First Quarter 2022 Financial Results

Bioceres Crop Solutions Corp. (NASDAQ:BIOX ) Q3 2022 Earnings Conference Call May 12, 2022 8:30 AM ET Company Participants Federico Trucco – Chief Executive Officer Enrique López Lecube – Chief Financial Officer Rodrigo Krause – Head of Investor Relations Conference Call Participants Ben Klieve – Lake Street Capital Market Brian Wright – ROTH Capital Partners Kemp Dolliver – Brookline Capital Markets Operator Hello, everyone, and welcome to today's Bioceres Crop Solutions Fiscal Third Year of Third Quarter 2022 Financial Results Conference Call. My name's Amarin, I will be coordinating your call today.

Bioceres Crop Solutions Corp. (BIOX) CEO Federico Trucco on Q3 2022 Results - Earnings Call Transcript

ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions Reports Fiscal Third Quarter 2022 Financial and Operational Results

Bioceres Crop Solutions Reports Fiscal Third Quarter 2022 Financial and Operational Results

S&W Seed

Trigall Genetics to potentially own a majority position in newly created Australian company, Trigall Australia, which would include the wheat breeding activity of S&W to further develop performant varieties for Australian farmers. Trigall Australia is expected to benefit from S & W´s existing footprint – including varieties, sales and marketing, Florimond Desprez's worldwide breeding expertise and Bioceres Crop Solutions´ drought-tolerance HB4® EcoWheat® technologies.

S&W and Trigall Genetics - a JV between Bioceres Crop Solutions and Florimond Desprez - Enter Discussions to Combine Wheat Efforts in Australia

CEDARHURST, N.Y.--(BUSINESS WIRE)--Kuznicki Law PLLC is investigating the proposed sale of Marrone Bio Innovations, Inc. (NasdaqCM: MBII) to Bioceres Crop Solutions Corp. (NasdaqGS: BIOX). Under the terms of the proposed transaction, shareholders of Marrone will receive only 0.088 shares of Bioceres for each share of Marrone that they own. If you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, contact us toll free at 833-938-0905,

MARRONE BIO INVESTOR ALERT - Kuznicki Law PLLC Investigates Proposed Sale of Marrone Bio Innovations, Inc. - MBII

ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions to Host Fiscal Third Quarter 2022 Financial Results Conference Call on Thursday, May 12, 2022 at 8:30 a.m. Eastern Time

Bioceres Crop Solutions to Host Fiscal Third Quarter 2022 Financial Results Conference Call on Thursday, May 12, 2022 at 8:30 a.m. Eastern Time

ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions Announces Regulatory Approval of HB4® Soy in China

Bioceres Crop Solutions Announces Regulatory Approval of HB4® Soy in China

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Marrone Bio Innovations, Inc. (NasdaqCM: MBII) to Bioceres Crop Solutions Corp. (NasdaqGS: BIOX). Under the terms of the proposed transaction, shareholders of Marrone will receive only 0.088 shares of Bioceres for each share of Marrone that they own. KSF is seeking to determine whether this consideration and t

MARRONE BIO INVESTOR ALERT by The Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Marrone Bio Innovations, Inc. - MBII

Bioceres has a profitable segment based on its subsidiary Rizobacter, that sells adjuvants, micro beaded fertilizers and other agricultural solutions.

Bioceres Has Not Resolved Its Major Risks And Is Growing Based On Commodities Bullishness

Wilmington, Delaware--(Newsfile Corp. - March 21, 2022) - Rigrodsky Law, P.A. is investigating Marrone Bio Innovations, Inc. ("Marrone") (NASDAQ: MBII) regarding possible breaches of fiduciary duties and other violations of law related to Marrone's agreement to be acquired by Bioceres Crop Solutions Corp. ("Bioceres") (NASDAQ: BIOX). Under the terms of the agreement, Marrone's shareholders will receive 0.088 shares of Bioceres common stock for each share of Marrone common stock they own.To learn more about this...

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Marrone Bio Innovations, Inc. Merger

ROSARIO, Argentina & RALEIGH, N.C.--(BUSINESS WIRE)--Bioceres Crop Solutions and Marrone Bio Announce Merger Agreement

Bioceres Crop Solutions and Marrone Bio Announce Merger Agreement

ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions to Attend the 34th Annual ROTH Conference March 13-15, 2022

Bioceres Crop Solutions to Attend the 34th Annual ROTH Conference March 13-15, 2022

Bioceres Crop Solutions Corp. (BIOX) CEO Federico Trucco on Q2 2022 Earnings Call Transcript

ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions Reports Fiscal Second Quarter 2022 Financial and Operational Results

Bioceres Crop Solutions Reports Fiscal Second Quarter 2022 Financial and Operational Results

ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions to Host Fiscal Second Quarter 2022 Financial Results Conference Call on Thursday, February 10, 2022 at 8:30 a.m. Eastern Time

Bioceres Crop Solutions to Host Fiscal Second Quarter 2022 Financial Results Conference Call on Thursday, February 10, 2022 at 8:30 a.m. Eastern Time

ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions Subsidiary Rizobacter Completes $20 Million Offering of Series VII Corporate Bonds

Bioceres Crop Solutions Subsidiary Rizobacter Completes $20 Million Offering of Series VII Corporate Bonds

ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions to Participate in Upcoming Investor Conferences

News for Bioceres Crop Solutions Corp Stock (BIOX)